Christine J. Guico-pabia - Net Worth and Insider Trading

Christine J. Guico-pabia Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christine J. Guico-pabia owns 1 companies in total, including Nabriva Therapeutics PLC (NBRVF) .

Click here to see the complete history of Christine J. Guico-pabia’s form 4 insider trades.

Insider Ownership Summary of Christine J. Guico-pabia

Ticker Comapny Transaction Date Type of Owner
NBRVF Nabriva Therapeutics PLC 2021-10-01 Chief Medical Officer

Christine J. Guico-pabia Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christine J. Guico-pabia Ownership Network

Ownership Network List of Christine J. Guico-pabia

No Data

Ownership Network Relation of Christine J. Guico-pabia

Insider Network Chart

Christine J. Guico-pabia Owned Company Details

What does Nabriva Therapeutics PLC do?

Who are the key executives at Nabriva Therapeutics PLC?

Christine J. Guico-pabia is the Chief Medical Officer of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .

Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nabriva Therapeutics PLC Insider Transactions

No Available Data

Christine J. Guico-pabia Mailing Address

Above is the net worth, insider trading, and ownership report for Christine J. Guico-pabia. You might contact Christine J. Guico-pabia via mailing address: C/o Nabriva Therapeutics Plc, 414 Commerce Drive, Suite 120, Fort Washington Pa 19034.